MY137442A - Nucleic acid coated particles - Google Patents

Nucleic acid coated particles

Info

Publication number
MY137442A
MY137442A MYPI20051572A MY137442A MY 137442 A MY137442 A MY 137442A MY PI20051572 A MYPI20051572 A MY PI20051572A MY 137442 A MY137442 A MY 137442A
Authority
MY
Malaysia
Prior art keywords
nucleic acid
particles
coated particles
acid coated
precipitating
Prior art date
Application number
Inventor
Chris Robert Lively
Robert Delong
Original Assignee
Powderject Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Res Ltd filed Critical Powderject Res Ltd
Priority to MYPI20051572 priority Critical patent/MY137442A/en
Publication of MY137442A publication Critical patent/MY137442A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PARTICLES ARE PROVIDED WHICH ARE SUITABLE FOR DELIVERY FROM A PARTICLE-MEDIATED DELIVERY DEVICE. THE PARTICLES ARE OBTAINED BY PRECIPITATING A NUCLEIC ACID ON INERT METAL CARRIER PARTICLES IN THE PRESENCE OF A NUCLEIC ACID CONDENSING AGENT AND A METAL ION CHELATING AGENT. ALSO DESCRIBED ARE PROCESSES FOR PREPARING THE PARTICLES, AND THERAPEUTIC METHODS USING THE PARTICLES INCLUDING METHODS OF NUCLEIC ACID IMMUNISATION AND GENE THERAPY.
MYPI20051572 2005-04-08 2005-04-08 Nucleic acid coated particles MY137442A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20051572 MY137442A (en) 2005-04-08 2005-04-08 Nucleic acid coated particles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20051572 MY137442A (en) 2005-04-08 2005-04-08 Nucleic acid coated particles

Publications (1)

Publication Number Publication Date
MY137442A true MY137442A (en) 2009-01-30

Family

ID=45689132

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20051572 MY137442A (en) 2005-04-08 2005-04-08 Nucleic acid coated particles

Country Status (1)

Country Link
MY (1) MY137442A (en)

Similar Documents

Publication Publication Date Title
GB0508110D0 (en) Gene delivery
WO2005072893A8 (en) Functionalized colloidal metal compositions and methods
WO2009154958A3 (en) Treatment of patient tumors by charged particle therapy
WO2006083300A3 (en) Acceleration of charged particles using spatially and temporally shaped electromagnetic radiation
WO2005084295A3 (en) Fused heterotricyclic compounds as inhibitors of 17b-hydroxysteroid dehydrogenase 3
WO2003000928A3 (en) Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof
WO2006135763A3 (en) Inhibitors of dna repair enzymes and methods of use thereof
WO2008054826A3 (en) Pathotropic targeted gene delivery system for cancer and other disorders
SG158097A1 (en) Method and apparatus to help promote contact of gas with vaporized material
WO2005030121A3 (en) Compounds, compositions and methods
WO2003097803A3 (en) Cancer-linked gene as target for chemotherapy
WO2003101400A3 (en) Cancer-linked gene as target for chemotherapy
MX2010005451A (en) System for delivery into a xcr1 positive cell and uses thereof.
HK1073130A1 (en) Anticancer agents using vero toxin variants
WO2005123141A3 (en) Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent
WO2005085188A3 (en) Compounds and methods for anti-tumor therapy
WO2004033666A3 (en) Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases
MX2008002233A (en) Ligands for metal ions and methods for making and using the same.
WO2009135019A3 (en) Methods and compositions for prostate cancer immunotherapy
EA200500546A1 (en) PARTICLES COATED BY NUCLEIC ACID
WO2008082558A3 (en) Anode for electrotransport of cationic drug
WO2007044627A3 (en) Compositions and methods for delivery of interfering rna
HK1078593A1 (en) Antibody against a tumor-specific antigen as target
WO2007006581A3 (en) Targeting lsd1 for use in identifying and/or scoring prostate cancer and for controlling anrogen receptor-dependent gene expression
WO2005079271A3 (en) Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer